Deferasirox Therapy Is Associated With Reduced Mortality Risk in a Medicare Population With Myelodysplastic Syndromes

Journal of Comparative Effectiveness Research - United Kingdom
doi 10.2217/cer.15.20
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Future Medicine Ltd

Related search

Hematologic Responses to Deferasirox Therapy in Transfusion-Dependent Patients With Myelodysplastic Syndromes

Haematologica
Hematology
2012English

Reduced PLCG1 Expression Is Associated With Inferior Survival for Myelodysplastic Syndromes

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Online Social Integration Is Associated With Reduced Mortality Risk

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis

Cancer
Cancer ResearchOncology
2017English

Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes

International Journal of Hematology
Hematology
2013English

Microarray Profiling Defines Circulating microRNAs Associated With Myelodysplastic Syndromes

Neoplasma
Cancer Research
2017English

Continuous Renal Replacement Therapy Is Associated With Reduced Serum Ammonia Levels and Mortality in Acute Liver Failure

Hepatology
MedicineHepatology
2017English

Heat Shock Protein 90 Is Overexpressed in High-Risk Myelodysplastic Syndromes and Associated With Higher Expression and Activation of Focal Adhesion Kinase

Oncotarget
Oncology
2012English

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events

Gastroenterology
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy